Highmount Capital’s Pfizer PFE Stock Holding History

Highmount Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$5.51M	Sell	173,281 -382	-0.2%	-$12.4K	1.41%	17
2015 Q1	$5.73M	Buy	173,663 +359	+0.2%	+$11.4K	1.39%	16
2014 Q4	$5.12M	Sell	173,304 -194	-0.1%	-$5.56K	1.25%	21
2014 Q3	$4.87M	Sell	173,498 -3,961	-2%	-$111K	1.21%	20
2014 Q2	$5M	Sell	177,459 -6,582	-4%	-$188K	1.2%	23
2014 Q1	$5.61M	Sell	184,041 -787	-0.4%	-$23.5K	1.3%	18
2013 Q4	$5.37M	Buy	184,828 +6,917	+4%	+$201K	1.23%	19
2013 Q3	$4.85M	Buy	177,911 +39,978	+29%	+$1.09M	1.2%	19
2013 Q2	$3.67M	Buy	+137,933	New	+$3.81M	0.96%	28

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Highmount Capital's PFE Position: Q2 2015 in Review

Highmount Capital reduced its Pfizer (PFE) stake by 0.22% in Q2 2015, selling an estimated $12.4K and leaving 173,281 shares worth $5.51M. The position accounts for 1.41% of the portfolio, ranked #17.

Highmount Capital first reported a position in PFE in Q2 2013 and has held it in 9 quarters since. The position peaked at $5.73M in Q1 2015. 1,888 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

Highmount Capital held 173,281 shares of Pfizer worth $5.51M as of Q2 2015.
Highmount Capital sold 382 Pfizer shares in Q2 2015, an estimated $12.4K.
Pfizer made up 1.41% of Highmount Capital's portfolio in Q2 2015, its #17 holding.
Highmount Capital first reported a position in Pfizer in Q2 2013 and has held it in 9 quarters since.
Highmount Capital's Pfizer position peaked at $5.73M in Q1 2015.
1,888 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on Highmount Capital's 13F filing for Q2 2015, filed 14 Aug 2015.